Cargando…

Decreased Prognostic Value of International Prognostic Score in Chinese Advanced Hodgkin Lymphoma Patients Treated in the Contemporary Era

BACKGROUND: The International Prognostic Score (IPS) was developed based on the data of Western advanced Hodgkin lymphoma (HL) patients treated before 1992. Only a few studies ever evaluated the application value of IPS in Chinese population or in patients treated in the contemporary era whose outco...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Qin, Qin, Yan, Kang, Su-Yi, He, Xiao-Hui, Liu, Peng, Yang, Sheng, Zhou, Sheng-Yu, Zhang, Chang-Gong, Gui, Lin, Yang, Jian-Liang, Sun, Yan, Shi, Yuan-Kai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5146782/ https://www.ncbi.nlm.nih.gov/pubmed/27900988 http://dx.doi.org/10.4103/0366-6999.194661

Ejemplares similares

Prognostic value of pretreatment serum beta-2 microglobulin level in advanced classical Hodgkin lymphoma treated in the modern era
por: Wang, Qin, et al.
Publicado: (2016)

Prognostic value of the albumin-bilirubin score in patients with non-Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis
por: Cheng, Wanying, et al.
Publicado: (2023)

Prognostic Factors in Hodgkin Lymphoma
por: Cuccaro, Annarosa, et al.
Publicado: (2014)

The Prognostic Significance of the Serum p53 Protein Concentration in Chinese Patients with Non-Hodgkin Lymphoma
por: Zhou, Min, et al.
Publicado: (2012)

Enhancement of the International prognostic index with β2-microglobulin, platelet count and red blood cell distribution width: a new prognostic model for diffuse large B-cell lymphoma in the rituximab era
por: Chen, Haizhu, et al.
Publicado: (2022)

Proliferation in Non-Hodgkin’S Lymphomas and Its Prognostic Value Related to Staging Parameters
por: Lorand‐Metze, Irene, et al.
Publicado: (2004)

Prognostic value of baseline metabolic tumour volume in advanced-stage Hodgkin’s lymphoma
por: Pinochet, Pierre, et al.
Publicado: (2021)

Incremental prognostic value of lung ultrasound on contemporary heart failure risk scores
por: Maestro-Benedicto, Alba, et al.
Publicado: (2022)

The Outcome of Hodgkin Lymphoma With Reference to Prognostic Markers
por: Ahmed, Rehana, et al.
Publicado: (2022)

Prognostic value of lymphocyte-monocyte ratio at diagnosis in Hodgkin lymphoma: a meta-analysis
por: Lee, Shing Fung, et al.
Publicado: (2019)

The prognostic value of the myeloid-mediated immunosuppression marker Arginase-1 in classic Hodgkin lymphoma
por: Romano, Alessandra, et al.
Publicado: (2016)

The prognostic value of 18-FDG positron emission tomography in T cell non-Hodgkin lymphoma
por: Eslick, R, et al.
Publicado: (2017)

Prognostic Value of miRNA-155 Expression in B-Cell Non-Hodgkin Lymphoma
por: Bedewy, Ahmed M. L., et al.
Publicado: (2017)

Primary gastric non-Hodgkin's lymphoma in Chinese patients: clinical characteristics and prognostic factors
por: Huang, JiaJia, et al.
Publicado: (2010)

Contemporary Management of Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
por: Kurtin, Sandra E., et al.
Publicado: (2018)

The prognostic value of programmed cell death ligand 1 expression in non-Hodgkin lymphoma: a meta-analysis
por: Zhao, Shu, et al.
Publicado: (2018)

Prognostic Value of Pretreatment Serum Cystatin C Level in Nasopharyngeal Carcinoma Patients in the Intensity-modulated Radiotherapy Era
por: Tan, Xi-Rong, et al.
Publicado: (2021)

Meta-analysis of the prognostic and clinical value of tumor-associated macrophages in adult classical Hodgkin lymphoma
por: Guo, Baoping, et al.
Publicado: (2016)

Clinical and prognostic analysis of 78 patients with human immuno-deficiency virus associated non-Hodgkin’s lymphoma in Chinese population
por: Shen, Yang, et al.
Publicado: (2017)

Prognostic factors in high and intermediate grade non-Hodgkin's lymphoma.
por: Cowan, R. A., et al.
Publicado: (1989)

Prognostic factors in the non-Hodgkin's lymphomas--a time for consensus?
por: Child, J. A.
Publicado: (1991)

Frontline Therapy for Classical Hodgkin Lymphoma by Stage and Prognostic Factors
por: Allen, Pamela B, et al.
Publicado: (2017)

Prognostic Markers within the Tumour Microenvironment in Classical Hodgkin Lymphoma
por: Martynchyk, Arina, et al.
Publicado: (2023)

The Prognostic Value of Eight Immunohistochemical Markers Expressed in the Tumor Microenvironment and on Hodgkin Reed-Sternberg Cells in Pediatric Patients With Classical Hodgkin Lymphoma
por: Zijtregtop, Eline A. M., et al.
Publicado: (2022)

P1076: A RETROSPECTIVE ANALYSIS ON OLD AND EMERGING PROGNOSTIC FACTORS IN CLASSICAL HODGKIN’S LYMPHOMA IN THE PET-GUIDED ERA
por: Cellini, A., et al.
Publicado: (2022)

Redox Regulating Enzymes and Connected MicroRNA Regulators Have Prognostic Value in Classical Hodgkin Lymphomas
por: Karihtala, Peeter, et al.
Publicado: (2017)

The prognostic value of Epstein−Barr virus infection in Hodgkin lymphoma: A systematic review and meta-analysis
por: Hu, Jianyu, et al.
Publicado: (2022)

Comparison of the prognostic value of SYNTAX score and clinical SYNTAX score on outcomes of Chinese patients underwent percutaneous coronary intervention
por: Li, Xiao-Qin, et al.
Publicado: (2021)

The prognostic value of the Naples prognostic score for patients with non-small-cell lung cancer
por: Peng, Si-Min, et al.
Publicado: (2022)

Prognostic value of time to generalization in 71 Chinese patients with sporadic amyotrophic lateral sclerosis
por: Sun, Qiong-Hua, et al.
Publicado: (2019)

Assessing Prognostic Factors in Hodgkin's Lymphoma: Multistate Illness-Death Model
por: Javanmardi, Fatemeh, et al.
Publicado: (2018)

Combined Identification of Novel Markers for Diagnosis and Prognostic of Classic Hodgkin Lymphoma
por: Kuang, Zhixing, et al.
Publicado: (2021)

Interim FDG-PET/CT for therapy monitoring and prognostication in Hodgkin’s Lymphoma
por: Al-Ibraheem, Akram, et al.
Publicado: (2022)

Unraveling the Immune Microenvironment in Classic Hodgkin Lymphoma: Prognostic and Therapeutic Implications
por: Georgoulis, Vasileios, et al.
Publicado: (2023)

Prognostic value and clinicopathological characteristics of PD-L1 overexpression in non-Hodgkin lymphoma: a meta-analysis
por: Zeng, Qiang, et al.
Publicado: (2020)

Prognostic Nomogram and Predictive Factors in Refractory or Relapsed Diffuse Large B-Cell Lymphoma Patients Failing Front-Line R-CHOP Regimens
por: Jiang, Shiyu, et al.
Publicado: (2020)

Prognostic value of prognostic nutritional index score and controlling nutritional status score in patients with glioblastoma: A comprehensive meta-analysis
por: Peng, Jie, et al.
Publicado: (2023)

Prognostic value of pre-treatment Naples prognostic score (NPS) in patients with osteosarcoma
por: Yang, Qiankun, et al.
Publicado: (2020)

Neutrophil/Lymphocyte Ratio, Lymphocyte/Monocyte Ratio, and Absolute Lymphocyte Count/Absolute Monocyte Count Prognostic Score in Diffuse Large B-Cell Lymphoma: Useful Prognostic Tools in the Rituximab Era
por: Ho, Ching-Liang, et al.
Publicado: (2015)

Advanced Hodgkin Lymphoma: a New Era of Therapy
por: Dann, Eldad J.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_a7ek689i88hb60krs3hlmlns99